Market Research Report
qPCR and dPCR Markets (Instruments, Reagents, Software/Services)
|Published by||Kalorama Information||Product code||317962|
|Published||Content info||190 Pages
Delivery time: 1-2 business days
|qPCR and dPCR Markets (Instruments, Reagents, Software/Services)|
|Published: April 26, 2016||Content info: 190 Pages||
PCR, or polymerase chain reaction, is used to amplify a single copy or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence. The most notable use of qPCR is DNA sequencing and gene expression in research applications. qPCR is used in a variety of research areas including stem cell research, oncology and genetic disease research, pathogen detection and infectious disease research, plant sciences research and many others.
This report, qPCR and dPCR Markets contains essential market information for business planning and strategy, including the following:
qPCR is increasingly being used in the clinical/medical diagnostic arena for diagnosis of bacterial disease, detection of antibiotic resistance, diagnosis of infectious disease and quantification of bacterial load. It is also used to detect genetic abnormalities and cancer mutations. qPCR-based diagnostic tests are expected to expand in the coming years. However, these tests will have to meet three requirements: adaptation of existing diagnostic tests, especially according to the discovery of new variants of target genes of specific pathogens, responsible for false-negative results; expansion of diagnostic applications; and lower cost.
In this report, product offerings are reviewed in three areas
Most of the major companies such as Thermo Fisher Scientitic, Agilent, Roche and Bio-Rad offer qPCR software and services. Agilent - MXPro ET QPCR Thermo Fisher's Melt Software, Real Time Stat Miner Software, DataAssist. Bio-Rad - CFX Manager Software
There are a number of issues and trends affecting the total PCR Technologies industry. Some of these issues are affecting the entire medical industry such as an aging population, healthcare reform while others are unique to the qPCR and dPCR. The issues and trends affecting this market are:
The majority of competitive participation for PCR technologies in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. There are numerous companies in the market which include large multiproduct companies such as Thermo Fisher Scientific, Roche and Abbott and small niche developers such as RainDance Technologies.
Companies profiles in this report include: